Health knowledge made personal
Join this community!
› Share page:
Search posts:

Hormone Replacement Therapy Decrease Risk Of Cancer Austin Tx

Posted Apr 18 2014 1:34pm

Hormone Replacement Therapy Decrease Risk Of Cancer Austin Tx
Patients often have questions regarding hormone replacement and cancer risks. While not all cancers are influenced by hormone levels, malignancies that arise from hormone sensitive tissues often are. These hormone sensitive cancers include ovarian, endometrial, breast and prostate cancers.

One of the primary risk factors for endometrial cancer is unopposed estrogen [estrogen dominance]. This relationship came to light in the years following the introduction and widespread prescription of conjugated estrogen’s (Premarin) to millions of women in the US, resulting in an eight-fold increase in endometrial cancer. Since 1976, Premarin, and other medications that contain estrogen are required to carry a label warning about the risk of endometrial cancer. Conventional prescribing practices have been changed to include a progestin along with estrogen for women who have not had a hysterectomy.

The primary progestin prescribed to most women in this situation is medroxyprogesterone acetate (Provera), a synthetic molecule that binds to progesterone receptors in the endometrium [and breasts], but does not have the same effects in the rest of the body. While Provera may reduce the risk of endometrial cancer, it has multiple side effects including an increased risk of breast cancer and cardiovascular disease.

This is why women are warned by the News Media (and often their physicians) of the dangers of taking HRT (hormone replacement therapy). However, what the mean with this legitimate warning of the dangers of synthetic hormones is do not take the synthetic combination drug, Provera (or similar synthetic combinations with progestins).

This was made clear in 2002 when one arm of the Women’s Health Initiative was halted prematurely due to the increased incidence of breast cancer, heart disease and strokes in the study subjects for those women taking Provera.

1998: Am Clin Lab Sci 1998; 28:360-369
• Progesterone at high levels exhibits a powerful anti-proliferative effect on breast cancer cell lines.
• Progesterone inhibits growth and induces apoptosis (death) in breast cancer cell.

1995: Fertility Sterility 1995; 63: 785-91
• Estradiol stimulates milk duct tissue 230%.
• Progesterone (not progestin) decreased proliferation rate 400%.
• Evidence that unopposed estrogen stimulates hyperproliferation of breast epithelial and progesterone protects against hyperproliferation.

To see studies on the protective effects of bioidentical (natural) hormones,

Mike Clark is one of the Hormone Therapy Replacement and Diet Center’s owners. His company helps many of people with Hormonal problems, Weight loss problem, Diabetes and many more.

His website is

More Estrogen Articles

Post a comment
Write a comment: